Administration of 100 mg/Kg of the hypolipidemic drug Bezafibrate for five consecutive days to the rat causes a marked liver enlargement and an alteration of the mixed function oxidase (MFO) system. Cytochrome P-450 levels are increased in liver microsomes from treated rats by 80%, NADPH-cytochrome c reductase activity by 45% and aminopyrine N-demethylase activity by 40%. On the contrary, other MFO activities (p-nitroanisole O-demethylase, hexobarbital oxidase, aniline hydroxylase and zoxazolamine hydroxylase) remain unchanged. The type of P-450 hemoprotein induced shows different spectroscopic properties in the binding of CO, Type II and Type RI ligands in respect to cytochrome P-450 of the controls. These results reveal differential alterations of the MFO system and the induction of one specific type of cytochrome P-450 hemoprotein.

Effect of the hypolipidemic drug bezafibrate on the hepatic mixed function oxidase system of the rat: heterogeneity monooxygenase responses / R. Maffei Facino, M. Carini. - In: PHARMACOLOGICAL RESEARCH COMMUNICATIONS. - ISSN 0031-6989. - 13:9(1981), pp. 861-871.

Effect of the hypolipidemic drug bezafibrate on the hepatic mixed function oxidase system of the rat: heterogeneity monooxygenase responses

R. Maffei Facino
Primo
;
M. Carini
Ultimo
1981

Abstract

Administration of 100 mg/Kg of the hypolipidemic drug Bezafibrate for five consecutive days to the rat causes a marked liver enlargement and an alteration of the mixed function oxidase (MFO) system. Cytochrome P-450 levels are increased in liver microsomes from treated rats by 80%, NADPH-cytochrome c reductase activity by 45% and aminopyrine N-demethylase activity by 40%. On the contrary, other MFO activities (p-nitroanisole O-demethylase, hexobarbital oxidase, aniline hydroxylase and zoxazolamine hydroxylase) remain unchanged. The type of P-450 hemoprotein induced shows different spectroscopic properties in the binding of CO, Type II and Type RI ligands in respect to cytochrome P-450 of the controls. These results reveal differential alterations of the MFO system and the induction of one specific type of cytochrome P-450 hemoprotein.
Settore CHIM/08 - Chimica Farmaceutica
1981
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/182931
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 5
  • ???jsp.display-item.citation.isi??? ND
social impact